Sundry Images/iStock Editorial by way of Getty Photos
- Johnson & Johnson (NYSE:JNJ) unit Janssen was ordered to pay $1.64B after a New Jersey federal court docket jury discovered the drugmaker responsible of promoting two HIV medication for off-label makes use of.
- Choose Zahid Quraishi in Trenton mentioned that Janssen should pay $360M
